Ciprofibrate diminishes non-hdlc and improves hdlc in patients with frederickson type iv dyslipidemia phenotype

Documenti analoghi

• Ciprofibrate diminishes non-HDL-c and improves HDL-c in patients with frederickson type IV dyslipidemia phenotype
  di: Valmore Bermúdez-Pirela
  Pubblicazione: (2006)
• Distribución del polimorfismo G721A de ICAM-1 y niveles de séricos de HDLC y reactantes de fase aguda en pacientes mestizos mexicanos con osteoartritis
  di: F.A. Amador Amador
  Pubblicazione: (2007)
• Lipoprotein a: Extreme Elevation and Genetic Polymorphism Association with Cardiac and Vascular Lesions Evaluated by Computed Tomography
  di: Pablo Corral
  Pubblicazione: (2017)
• Lipofundin 20% induces hepatic lipid peroxidation in New Zealand white rabbits
  di: Livan Delgado R
  Pubblicazione: (2012)
• Cholesterol, glucose and triglycerides role in the prevalence of hyperlipidemia in dogs at higher elevations
  di: Carla Verónica Barriga
  Pubblicazione: (2011)